By Morgan N. Fredell, Hagop M. Kantarjian, Ya-Chen Shih, Vivian Ho and Binata Mukherjee
Current U.S. health care spending includes many areas of wasted expenditures. In this study, published in Cancer, the authors explore plans to optimize U.S. health care to provide greater benefits to patients: https://bit.ly/2TmeoDg
The authors examine the relationship between market competition and the use of surgical services for cancer to test the theory that market competition promotes patient access and health care delivery.
Marcelo Cerullo, Clara Lee, Anaeze C. Offodile IIDecember 1, 2018
Corruption is a complex social, political and institutional problem that is difficult to define. This brief describes the challenges involved in defining, understanding and measuring corruption and evaluates the case study of Mexico, where corruption has increased in recent years, to illustrate these complexities.
The author analyzes the major claims and implications of the Surgeon General's report "Facing Addiction in America," and proposes additional drug policy considerations for addressing substance use disorders.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
This compilation of briefs addresses a range of issues the new administration will face in the coming years. “It is our hope that these Baker Institute studies will prove to be useful starting points for the new administration to develop comprehensive, forward-looking solutions," said Baker Institute Director Edward Djerejian.
State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.
This blog post examines four factors of globalization that make Texas a “ground zero” for new infectious tropical diseases and outlines steps the state must take to better mitigate global health threats.